I am not sure, pharma.
It seems to me that treating patients with the midkine protein has potential in some indications, whereas inhibiting it is a strategy for other indications.
I was hoping that someone with the right background might find the time to comment. There used to be a user here with a medical background who commented rarely, but I haven't read from her or him in a while.
Midkine Study: Important Role in Pediatric Heart Failure, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
